Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500406 · ClinicalTrials.gov registry record · NA
Penile Lengthening Pre-Penile Prosthesis Implantation
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03500406: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03500406 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03500406, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is intended to utilize a novel, class I (ie. lowest risk, clinical studies not required) medical device to determine whether penile length can be increased in men prior to undergoing a penile prosthesis implantation procedure.
Interventions
- OTHER Control
- DEVICE RestoreX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-03-23 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500406
The ClinicalTrials.gov registry entry for NCT03500406 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03500406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500406 about?
NCT03500406 is a clinical study titled "Penile Lengthening Pre-Penile Prosthesis Implantation". This study is intended to utilize a novel, class I (ie. lowest risk, clinical studies not required) medical device to determine whether penile length can be increased in men prior to undergoing a penile prosthesis implantation procedure.
What is the current status of trial NCT03500406?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2018-03-23. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03500406?
The interventions under investigation include: Control (OTHER), RestoreX (DEVICE).
Who is sponsoring clinical trial NCT03500406?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.